Diabetes mellitus represents one of the most powerful and prevalent cardiometabolic risk factors facing U.S. adults today. Test your knowledge about diabetes prevalence.
A large 2023–2024 survey of 21,000 US adults provides updated, medication-specific prevalence data on OTC and prescription use within a 7-day window. Do you know how many adults reported taking at least one...
Disorders of gut–brain interaction are defined not by biomarkers but by symptoms. How well do you understand the physiologic principles behind functional dyspepsia, IBS, and chronic constipation? Take this...
Test your knowledge on the prevalence of FDA-approved indications for novel cardiovascular-kidney-metabolic therapies and the implications for clinical practice.
Primary care clinicians are often the first point of contact for patients with mood and anxiety symptoms, yet time constraints make comprehensive psychiatric evaluation impractical in many visits. Brief...
The 2026 Cardiovascular Statistics report provides a comprehensive review of trends in major cardiovascular risk factors—including hypertension, diabetes, obesity, dyslipidemia, and smoking—as well as the 5...
Trends from the National Cancer Database show that the use of neoadjuvant systemic therapy (NST) has increased sharply over the past decade but not uniformly across cancer types or stages. Test your...
According to research published in JAMA Surgery, missed opportunities for risk assessment and surgical prevention are common among ovarian cancer patients with high-grade serous cancer (HGSC). Take this...
Telehealth adoption accelerated rapidly during and after the COVID-19 pandemic, raising concerns that greater convenience might drive higher outpatient utilization. However, recent evidence from Medicare...
Novel therapies are reshaping how clinicians think about triglyceride management and residual cardiovascular risk. This quick quiz tests your knowledge of the emerging data on APOC3 inhibition and its...
